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Bcl-2 Rescues T Lymphopoiesis,
but Not B or NK Cell Development,
in Common g Chain±Deficient Mice
Motonari Kondo,*² Koichi Akashi,* Jos Domen,* in IL-7Ra KO mice (He and Malek, 1996; Maki et al.,
1996). NK cell development is inhibited in mice deficientKazuo Sugamura,² and Irving L. Weissman*
for IL-2Rb (Suzukiet al., 1997), which is an indispensable*Departments of Pathology and
subunit of the functional IL-2R and IL-15R complexesDevelopmental Biology
(Giri et al., 1994). Since IL-2 KO mice have normal NKStanford University School of Medicine
cells, it could be that the impaired development of NKStanford, California 94305
cells in gc KO mice is due to a lack of functional IL-15R²Department of Microbiology and
(KuÈ ndig et al., 1993).Immunology
gc plays a role in the maintenance of cell survival, atTohoku University School of Medicine
least in the T cell lineage, through interactions betweenSendai 980±77
cytokines and cytokine receptors that require the gcJapan
subunit. In peripheral T cells from gc KO mice, low levels
of endogenous Bcl-2 expression correlate with impaired
in vitro survival (Nakajima et al., 1997). Recently we re-Summary
ported that IL-7 maintains the expression of endoge-
nous Bcl-2 in the T lineage cells and that the forcedThe common cytokine receptor g chain (gc) is an indis-
expression of Bcl-2 in the T lineage could significantlypensable subunit for the formation of lymphoid-related
restore positive selection of T cells in IL-7Ra KO micecytokine receptors, including IL-7 and IL-15 receptors,
(Akashi et al., 1997), although the restoration of T lym-that mediate nonredundant or critical signals for the
phopoiesis was not complete. Since Bcl-2 has beendifferentiation of T and B cells and natural killer (NK)
shown to maintain cell survival (Cory, 1995; Yang andcells, respectively. We introduced the bcl-2 transgene
Korsmeyer, 1996), it is strongly suggested that thedriven by Em or H-2K promoters into gc-deficient mice
gc-mediated defect in T lymphopoiesis may be due tothat lack all three lymphoid subclasses. The forced
a lack of survival signals from IL-7R. However, it is un-expression of Bcl-2 restored all stages of T lymphopoi-
known whether Bcl-2 can substitute for IL-7R±mediatedesis, but not B or NKcell development, indicating that a
signals in early T cell development, because the Em-bcl-primary function of gc-mediated signals in theT lineage 2-25 transgene failed to be expressed in the earliestmight be to maintain cell survival. Therefore, the devel-
thymic precursors such as CD32CD252c-Kit1 cellsopment of T, B, and NK cells may be influenced by
(Akashi et al., 1997). In addition, the restoration of Tdistinct intracytoplasmic signaling cascades that are
lymphopoiesis in bcl-2 transgenic IL-7Ra KO mice could
activated by coupling of gc-related receptors. be due to substitution for signals mediated by receptors
other than IL-7R, since the IL-7Ra chain has been shown
to be shared at least by one other cytokine receptor,
Introduction thymic stromal cell±derived lymphopoietin receptor
(Friend et al., 1994).
The common cytokine receptor g chain (gc) is a shared To clarify the role of survival signals mediated by
subunit of receptors for interleukin-2 (IL-2) (Takeshita et gc-related cytokines in all stages of lymphopoiesis, we
al., 1992), IL-4 (Kondo et al., 1993; Russell et al., 1993), crossed gc KO mice with Em-bcl-2-25 transgenic mice
IL-7 (Noguchi et al., 1993a; Kondo et al., 1994), IL-9 and H2K-bcl-2 transgenic mice. In the H2K-bcl-2 trans-
(Kimura et al., 1995), and IL-15 (Giri et al., 1994). A muta- genic mice, the human bcl-2 transgene was driven by
tion in the gc gene can result in a nonfunctional receptor a major histocompatibility (MHC) class I promoter and
and cause X-linked severe combined immunodeficiency a Moloney long terminal repeat, and therefore Bcl-2 is
(X-SCID) in humans (Noguchi et al., 1993b; Puck et al., expressed in virtually all developmental stages of hema-
1993). X-SCID is characterized by a severe impairment topoietic cells (J. D. and I. L. W., unpublished data). The
of T and natural killer (NK) cell development. Genetic enforced expression of Bcl-2 in gc KO mice throughout
ablationof the gc chain in mice causes a severe reduction each stage of lymphopoiesis resulted in the restoration
in the numbers of B cells as well as T and NK cells (Cao of T lymphopoiesis, but neither B nor NK cells were
et al., 1995; DiSanto et al., 1995; Ohbo et al., 1996). rescued. Signals mediated by the gc chain other than
These data indicate that the gc chain is an indispensable survival signals might be indispensable for the develop-
molecule for the development of all three classes of ment of B and NK cells.
lymphocytes.
Among cytokine receptors in which the gc chain is Results
used, the IL-7 receptor (IL-7R) transmits the nonredun-
dant signals for maintaining T and B lymphopoiesis. Enforced Expression of Bcl-2 Restores Peripheral
Both IL-7 knockout (KO) and IL-7Ra KO mice have a T Cells but Not B Cells in gc-Deficient Mice
reduction in the number of T and B cell precursors We have found that human Bcl-2 is expressed in all
(Peschon et al., 1994; von Freeden-Jeffry et al., 1995), hematopoietic cells, including hematopoietic stem cells
a phenotype that resembles that of gc KO mice (Cao et in H2K-bcl-2 transgenic mice (J. D. and I. L. W, unpub-
al., 1995; DiSanto et al., 1995; Ohbo et al., 1996). On the lished data). Figure 1 (top row) shows human Bcl-2 ex-
pression in blood cells. There is no significant differenceother hand, the development of NK cells is not affected
Immunity
156
Figure 1. Flow Cytometric Analysis of Nucle-
ated Blood Cells in Each Mouse Strain
(Top row) Expression of the transgene-
derived human Bcl-2 protein. The Em-bcl-2
transgene was expressed predominantly in T
cells (z85% of T cells), whereas the H2K-
bcl-2 transgene was expressed in virtually all
nucleated cells in blood.
(Bottom three rows) CD3/Gr-1, B220/Mac-1,
and CD4/CD8 profiles in nucleated blood
cells. Numbers accompanying inset boxes in-
dicate the percentage of each population in
nucleated blood cells.
in expression levels of human Bcl-2 protein in T cells Although the introduction of either of the two bcl-2
transgenes restored T lymphopoiesis, it did not rescuebetween Em-bcl-2 and H2K-bcl-2 transgenic mice. How-
ever, the Em-bcl-2 transgene was expressed in approxi- the development of B cells in either line (Figure 2A): the
absolute number of blood B2201 cells in gc KO micemately 85% of CD31 T cells, while the H2K-bcl-2
transgene was expressed in virtually all blood leuko- was 0.64% of the number seen in gc1 mice. In Em-bcl-2
gc KO mice and H2K-bcl-2 gc KO mice, the numbers ofcytes. Figures 1 and 2 show the results from an analysis
of peripheral blood from each mouse line. Consistent B2201 cells in blood were 1.1% and 1.6% of gc1 wild-
type levels. Although the differences between B cellwith previous reports, the gc KO mice showed a signifi-
cant reduction in the numbers of CD31 T cells and B2201 numbers in gc KO mice and gc KO mice with bcl-2
transgenes were small, the differences were statisticallyB cells (Cao et al., 1995; DiSanto et al., 1995; Ohbo et
al., 1996), whereas the numbers of Gr-11 granulocytes significant by theMann-Whitney and Wilcoxon nonpara-
metric tests (Figure 2A).remained normal. The ratios of CD41CD31 cells to
CD81CD31 cells were widely variable, but were higher
than the ratios found in wild type (Figures 1 and 2B), as Enforced Expression of Bcl-2 Restores T Cell
Maturation in the Thymus of gc-Deficient Micereported previously (Nakajima et al., 1997).
Introduction of the bcl-2 transgenes significantly re- We have reported that the enforced expression of an Em-
bcl-2 transgene could significantly rescue the positivestored the T cell numbers in the blood of gc KO mice.
In Em-bcl-2 gc KO and H2K-bcl-2 gc KO mice, the number selection process in IL-7Ra KO mice (Akashi et al., 1997).
Similar to the results obtained with the IL-7Ra KO mice,of CD31 cells increased approximately 3-fold (to 20%
of gc1 wild-type levels) and approximately 10-fold (to we found that both the absolute number of thymocytes
and the number of CD691 thymocytes that had recently50% of gc1 wild-type levels), respectively (Figure 2A).
The ratio of CD41CD31 cells to CD81CD31 cells in both received positive selection were significantly increased
in Em-bcl-2 gc KO and H2K-bcl-2 gc KO mice (Table 1).bcl-2 transgenic gc KO mouse strains was also nearly
normal (Figures 1 and 2B). There was no Vb-specific The ratio of CD41CD82 to CD42CD81 single-positive
thymocytes in gc KO mice was apparently higher thanrestoration of peripheral CD4 or CD8 cells in either Em-
bcl-2 gc KO and H2K-bcl-2 gc KO mice (data not shown). in normal mice, as reported previously, but both bcl-2
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Figure 2. Enforced Expression of Bcl-2 Re-
stores Mature T Cells and Normalizes the Ra-
tio of CD41 to CD81 T Cells in gc KO Mice
(A) Absolute numbers (cells per microliter) of
blood CD31, B2201 and Gr-11 cells. Asterisk,
p , 0.05 by the Mann-Whitney and Wilcoxon
nonparametric tests.
(B) The ratio of CD31CD41 to CD31CD81 sin-
gle-positive cells in each mouse strain.
Open circles, gc KO mice; filled squares, Em-
bcl-2 gc KO mice; filled circles, H2K-bcl-2 gc
KO mice; open squares, control gc1 mice.
Mean values are indicated by the bars and
adjacent numbers.
transgenes restored the normal ratio (Figure 3A). The mice, suggesting that gc-mediated signals (probably
IL-7R±mediated signals) might be critical for the ex-restoration of developing thymocytes was more signifi-
cant in the H2K-bcl-2 gc KO mice. This might be ex- pansion of thymocytes at these stages. Both bcl-2
transgenes significantly restored these thymic precur-plained by the expression of the H2K-bcl-2 transgene
in virtually all thymocytes (data not shown), whereas sors (Figure 3B). These data indicate that Bcl-2 rescues
the expansion of thymic precursors as well as thymicthe Em-bcl-2 transgene is not expressed in early thymic
precursors, including theearliest CD32CD252c-Kit1 thy- positive selection.
mic precursors (Akashi et al., 1997).
Figure 3B shows the c-Kit and CD25 profiles of the Enforced Expression of Bcl-2 Does Not Restore
Bone Marrow B Cell PrecursorsCD32 thymic population in each mouse strain. The earli-
est thymic precursors that have the potential to develop in gc-Deficient Mice
As shown in Figures 1 and 2A, B2201 cells in bloodinto B and NK cells as well as T cells (Wu et al., 1991;
Matsuzaki et al., 1993) are contained in the CD32CD252 remained scarce in both Em-bcl-2 gc KO and H2K-bcl-2
gc KO mice, but the increases in absolute numbers of Bc-Kithi fraction (fraction I). The CD32CD251c-Kitlo-hi cells
(fractions II and III) have already formed pre-T cell recep- cells in these mouse strains were statistically significant
compared to gc KO mice, suggesting that the enforcedtor complexes (Saint-Ruf et al., 1994), and their prolifera-
tion is synergistically supported by IL-7 and steel factor expression of Bcl-2 may result in accumulation of the
rare mature B cells, as previously reported (MacDonnell(Slf) (Godfrey et al., 1993). As shown in Table 1, the
absolute numbers of these c-Kit1 fractions were very et al., 1989; Strasser et al., 1991a). To assess the effect
of Bcl-2 on B cell development in gc KO mice morelow in gc KO mice. Enforced expression of Bcl-2 signifi-
cantly restores the numbers of c-Kit1 precursors; 1.5- clearly, we analyzed the B cell precursor populations in
the bone marrow in each mouse line.fold and 12-fold increases in CD32c-Kit1 precursors
were seen in Em-bcl-2 gc KO and H2K-bcl-2 gc KO mice, Table 1 shows absolute numbers of various bone mar-
row B cell populations (Hardy et al., 1991). Mature bonerespectively. Among the c-Kit1 populations, the transi-
tion of CD32CD251c-Kithi (fraction II) to CD32CD251c- marrow B cells (B2201IgM1) were missing in gc KO mice
irrespective of the presence of bcl-2 transgenes (FigureKitlo (fraction III) was severely suppressed in the gc KO
Table 1. Absolute Numbers of Cells in Thymus and Bone Marrow Subpopulations
Thymus Bone Marrow
(3 105) (3 105)
B2201 B2201
Mouse Total CD691 CD32c-Kit1 Total B2201IgM1 IgM2CD432 IgM2CD431
gc KO 68 6 14 5.5 6 1.5 0.098 6 0.053 420 6 76 0.19 6 0.13 1.0 6 0.74 8.8 6 2.8
Em-bcl-2 gc KO 280 6 120a 37 6 2.1a 0.14 6 0.023 480 6 73 0.20 6 0.084 0.88 6 0.45 9.0 6 1.5
H2K-bcl-2 gc KO 410 6 120a 54 6 12a 1.2 6 0.52a 360 6 88 0.21 6 0.11 0.96 6 0.77 6.7 6 1.5
gc
1 (wild type) 2100 6 380 270 6 40 6.9 6 1.8 560 6 82 66 6 13 110 6 30 35 6 12
Numbers of cells in bone marrow harvested from bilateral tibiae and femurs. Results are shown as means 6 SD from 3±5 mice.
a Significant increases in numbers of thymocyte subpopulations in bcl-2 transgenic gc KO mice as compared to those in gc KO mice (p , 0.05
by Student's t tests).
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Figure 3. Enforced Expression of Bcl-2 Re-
stores Development of Thymocytes in gc KO
Mice
(A) CD4/CD8 profiles of total thymocytes in
each mouse strain. Percentages of each sub-
set (of total thymocytes) are also shown.
(B) c-Kit/CD25 profiles of CD32 thymocyte
populations. Percentages of each fraction (I±
III) in CD32 thymocytes are indicated.
4A). We subdivided the B2201IgM2 B cell precursors did not restore the pro-B and pre-B cell populations;
as shown in Figure 4B, the transition from B2201IgM2into two populations based on the expression of CD43
(Figure 4B). The B2201IgM2CD431 cells are reported to CD431 pro-B to B2201 IgM2CD432 pre-B stages re-
mained impaired, and absolute numbers of both popula-be pro-B cells that are rearranging the m heavy chain
genes, and B2201IgM2CD432 cells are pre-B cells that tions remained low in both gc KO lines with bcl-2
transgenes (Table 1). Accordingly, the bcl-2 transgenehave completed rearrangement of the m heavy chain
genes and are rearranging the light chain genes (Hardy did not affect the distribution and numbers of B cell
precursors and mature B cells in the bone marrow, indi-et al., 1991). H2K-bcl-2 gc KO mice expressed Bcl-2 in
virtually all immature B2201IgM2 cells, while the Em- cating that the receptor complexes, including gc, medi-
ate developmental rather than survival signals in B lym-bcl-2 transgene was expressed in 15%±25% of imma-
ture B2201IgM2 cells (Figure 4C). The bcl-2 transgenes phopoiesis.
Figure 4. Enforced Expression of Bcl-2 Can-
not Rescue B Cell Development in gc KO Mice
Flow cytometric analysis of bone marrow B
cell precursors in each mouse strain.
(A) IgM/B220 profiles of total bone marrow
cells. gc KO mice lack mature B2201IgM1
cells irrespective of the introduction of bcl-2
transgenes.
(B) CD43/B220 profiles of IgM2 population.
The transition from the IgM2B2201CD431
pro-B to the IgM2B2201CD432 pre-B stage
was apparently impaired in gc KO strains. The
numbers above the inset squares are the per-
centages of cells within the gate (of total bone
marrow cells).
(C) bcl-2 transgene expression in B2201IgM2
B cell precursors in bone marrow of each
bcl-2 transgenic gc KO strain (shaded histo-
grams). Open histograms represent those of
gc KO mice as negative controls. Virtually all
B cell precursors in H2K-bcl-2 gc KO mice
expressed human Bcl-2.
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(Strasser et al., 1991b) into IL-7R±deficient mice (Mara-
skovsky et al., 1997). Although it remains possible that
Bcl-2 plays a role in activating intracellular maturation
programs in these experiments, these data strongly sug-
gest that cell survival signals are the principal function
of certain cytokines, including IL-7 and M-CSF.
In this study, the bcl-2 transgenes significantly re-
stored T cells, but not B or NK cells, in a gc KO mouse
that is a mouse model of X-SCID in humans. The restora-
tion of T cells in these bcl-2 transgenic gc KO mice could
be ascribed to the rescue of thymocytes undergoingFigure 5. Enforced Expression of Bcl-2 Cannot Rescue NK Cell De-
positive selection. Since Bcl-2 itself does not supportvelopment in gc KO Mice
thymic positive selection in the absence of MHC (LinetteFlow cytometric analysis of nucleated cells in the spleen. Numbers
et al., 1994; Tao et al., 1994; Akashi et al., 1997), thisaccompanying inset boxes indicate the percentage of the gated
population in splenocytes. NK1.11CD32 NK cells could not be de- study shows that Bcl-2 can substitute for signals from
tected in either H2K-bcl-2 gc KO or gc KO mice. gc-related cytokine receptors during positive selection.
Together with the recovery of T lymphopoiesis in
Em-bcl-2 IL-7Ra KO mice (Akashi et al., 1997), it is
Enforced Expression of Bcl-2 Does Not strongly suggested that Bcl-2 substitutes mainly for
Restore NK Cells in gc-Deficient Mice IL-7R±mediated survival signals so that they can com-
We could not detect a significant number of NK cells plete their developmental programs as directed by posi-
in either blood or spleens of gc KO mice, as reported tive selection signals from T cell receptor±MHC inter-
previously (Cao et al., 1995; DiSanto et al., 1995; Ohbo action.
et al., 1996). Neither the H2K-bcl-2 nor the Em-bcl-2 The gc-related cytokines (mainly IL-7) might also play
transgene could rescue NK cell development in the gc an important role at the early stage of thymic develop-
KO mice; as shown in Figure 5, NK1.11CD32 cells were ment; the restoration of T lineage cells was more pro-
absent from the spleens of H2K-bcl-2 gc KO mice, al- found in H2K-bcl-2 gc KO mice than in Em-bcl-2 gc KO
though the H2K-bcl-2 transgene is expressed in the mice. This might be because the H-2K promotor effi-
NK1.11CD32 NK cells (J. D. and I. L. W., unpublished ciently drives bcl-2 transgene expression in all stages
data). of T cell development, including the earliest thymic pre-
cursors. Since the proliferation of CD32CD251c-Kit1
Discussion thymic precursors are dependent on Slf as well as IL-7
(Suda and Zlotnik, 1991; Rodewalt et al., 1995), the en-
Interaction between cytokines and cytokine receptors forced expression of Bcl-2 might substitute for IL-7±
appears to signal cells to proliferate, to induce the ex- mediated survival signals that would allowthem to prolif-
pression of lineage-associated genes (differentiation), erate in the presence of c-Kit± and pre-T cell receptor
and to maintain their survival (Watowich et al., 1996). complex±mediated signals (Fehling et al., 1995; Akashi
These various roles of cytokines may be ascribed to the et al., 1997). However, it is possible that IL-7 may in part
activation of independent signaling pathways initiated play a role in the proliferation of thymocytes, because
from the different functional domains of the signaling the restoration is significant but not complete even in
subunits of cytokine receptors (Fukunaga et al., 1993; H2K-bcl-2 gc KO mice.
Kinoshita et al., 1995; Fukada et al., 1996). A significant On the other hand, the enforced expression of Bcl-2
role for some cytokines seems to be to prevent cells could restore neither matureB cells norB cell precursors
from undergoing apoptosis, rather than to direct cell in gc KO mice. The slight increase in blood B2201 cells
differentiation and/or proliferation; various cytokine- might be the result of prolonged cell survival, because
dependent cell lines that undergo apoptotic cell death expression of Bcl-2 promotes accumulation of B cells
after cytokine deprivation survive and complete their (MacDonnell et al., 1989; Strasser et al., 1991a). Among
differentiation program in vitro after introduction of sur- gc-related cytokines, IL-7 has been shown to induce
vival genes such as bcl-2 (Fairbairn et al., 1993; Cory, nonredundant signals in B as well as T cell development
1995; Yang and Korsmeyer, 1996). (Peschon et al., 1994; von Freeden-Jeffry et al., 1995).
We have recently shown that Bcl-2 can substitute for This nonredundancy may be attributable to the critical
signals induced by cytokines such as IL-7 and macro- role of IL-7 on two stages of B cell development: it has
phage colony- stimulating factor (M-CSF) in vivo; intro- been shown that IL-7 promotes rearrangement of the m
duction of the Em-bcl-2 transgene in IL-7Ra KO mice heavy chain gene of pro-B cells at least invitro (Corcoran
resulted in rescue of T lymphopoiesis (Akashi et al., et al., 1996) and stimulates proliferation of pre-B cells
1997), and introduction of the bcl-2 transgene into my- (Reichman-Fried et al., 1993; Spanopoulou et al., 1994;
elomonocytic cells resulted in significant recovery of Young et al., 1994). These two events might be closely
macrophage development and bone remodeling in os- related because during the transition from the pro-B to
teopetrotic M-CSF±deficient mice (op/op mice) (La- the pre-B stage, the formation of the pre-B receptor
gasse and Weissman, 1997). In addition to our reports, complex that is composed of a m chain and surrogate
others also have reported the rescue of T lymphocyte light chains (l5 and VpreB) is indispensable for prolifera-
tion (Karasuyama et al., 1996). The impairment of thedevelopment by introducing the Em-bcl-2-38 transgene
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Antibodiestransition from pro-B to pre-B in gc KO mice suggests
Antibodies used for flow cytometric analysis were as follows. Fluo-an important role for IL-7 (or other gc-related cytokines)
rescein isothiocyanate (FITC)± or phycoerythrin (PE)±conjugatedin m heavy chain gene rearrangement or in formation of
anti-CD3 (KT31.3), allophycocyanin (APC)±conjugated anti-c-Kit
the pre-B receptor complex in vivo. Alternatively, since (2B8), PE- or APC-conjugated anti-B220 (RA-6B2), FITC-conjugated
IL-7 plays a role in the proliferation of cells on the transi- anti-Mac-1 (M1/70), FITC-conjugated anti-Gr-1 (RB6±8C5), and
FITC-conjugated anti-IL-2Ra (PC61) were affinity purified from cul-tion from the pro-B to the pre-B stage (Karasuyama et
ture supernatant from hybridoma cells with protein G column chro-al., 1996), this phenotype may result simply from impair-
matography (protein G±Sepharose, Pharmacia, Uppsala, Sweden)ment of proliferation of these cells. IL-7 signaling also
and labeled in our laboratory. FITC- or PE-labeled anti-CD43 (S7)plays a role in differentiation of pre-B cells, since the cell
and FITC-labeled anti-CD69 (H1.2F3), Texas Red-labeled anti-IgM
surface aminopeptidase BP-1/6C3 expression in pro-B (affinity purified rabbit polyclonal antibody), and FITC-labeled anti-
cells can be induced by IL-7 (Sherwood and Weissman, human Bcl-2 (clone 124), which were purchased from Pharmingen
(San Diego, CA), Caltag (Burlingame, CA), and DAKO (Carpinteria,1990). This study shows that Bcl-2 cannot substitute for
CA), respectively. PE-labeled anti-IgM (clone 331) was obtainedIL-7R signaling in these processes of B cell devel-
from L. A. Herzenberg (Stanford University School of Medicine).opment.
Although common lymphoid progenitors in bone mar-
Preparation of Cell Suspensionsrow (M. K. et al., unpublished data) as well as the earliest
Cells were obtained from thymi and spleens that were crushed
thymic precursors (Rodewald et al., 1992; Matsuzaki et between glass slides and resuspended in staining medium (Hank's
al., 1993) have been shown to give rise to NK cells in balanced salt solution with 2% fetal calf serum and 0.02% NaN3).
vivo, the precise maturation pathway of NK cells has Cell suspensions from bone marrow were obtained by flushing fe-
murs and tibiae with the staining medium. Cells were treated withnot been clarified. gc KO mice have been shown to lack
ammonium chloride±potassium bicarbonate (ACK) solution (150mMNK cells (Cao et al., 1995; DiSanto et al., 1995; Ohbo et
NH4Cl and 10 mM KHCO3) to lyse red blood cells. Cell debris wereal., 1996). This deficiency may be due to the lack of
depleted by passage through nylon mesh screens, and cells were
formation of functional IL-15R in the mice (Giri et al., counted with a Coulter Counter model ZM (Coulter, Miami, FL).
1994; Suzuki et al., 1997). The critical stage of NK cell Bloodsamples were collected from tail veins into10 ml of 0.1 M EDTA
development that is supported by gc-mediated signals in phosphate-buffered saline in microcentrifuge tubes. Nucleated
blood cells were counted with a Coulter Counter after treatment(including IL-15R±mediated signals) is still unclear. As
with Zap-Oglobin II (Coulter). For antibody stainings, nucleated cellsin the case of B lineage cells, gc-mediated signals may
were enriched by Dextran segmentation using 0.5% Dextran inbe necessary to direct the differentiation program of
phosphate-buffered saline and treated with ACK.
NK cell maturation or may be important for expanding
NK cell precursor populations at certain maturational Flow Cytometric Analysis
stages. Cells (1 3 106) were stained in 50 ml of staining medium with fluoro-
Thus, this study suggests that in addition to survival chrome-conjugated antibodies on ice for 20 min. After the cells were
washed with staining medium, they were resuspended in stainingsignals in T cell development, gc-related cytokines in-
medium with propidium iodide. Intracytoplasmic human Bcl-2 stain-duce a variety of signals in the development of lymphoid
ing was performed as described previously (Akashi et al., 1997); thecells. Janus kinase 1 (Jak1) and Jak3 tyrosine kinases
cells were suspended in 50 ml of staining media containing 0.03%
are commonly used as triggering molecules in signal saponin and FITC-conjugated anti-human Bcl-2 for 30 min. Cells
transduction pathways initiating from gc-related recep- were analyzed on a highly modified FACS II (Beckton Dickinson,
tor complexes, including IL-7R and IL-15R (Ihle, 1995). Mountain View, CA) with dual lasers (488 nm argon laser and 599
nm dye laser) or FACScan (Beckton Dickinson) at the StanfordSince Bcl-2 could substitute for nonredundant signals
sharedFACS facility. Fluorescence data wereanalyzed by the FACS/from IL-7R in T lymphopoiesis but not in B lymphopoie-
DESK program and presented as two-parameter probability plotssis, the results strongly suggest that intracytoplasmic
(5%) or histograms.
signaling cascades activated by heterodimerization of
IL-7Ra and gc might be different for T and B cell matura- Acknowledgments
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